Business
Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, are pushing Mylan to take Teva’s $40 billion take-over bid offer seriously.
Hi, what are you looking for?
Jewish Business News
All posts tagged "Pharmaceutical Industry"
empty
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle with Mylan and Teva
Business
Teva Pharmaceutical Industries Ltd. has agreed to pay $1.2 billion in a settlement with the U.S. Federal Trade Commission (FTC), resolving claims that Cephalon...
Business
Teva CFO Eyal Desheh told Merrill Lynch that it could secure antitrust clearance for the takeover in 4-7 months.
Business
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
Business
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on...
Court
Tamir Capital is invested in Proneuron, which successfully sued Teva for abuse of a license for its product.
Business
Bloomberg reports that Teva is working with Barclays Bank on a takeover bid for Mylan.
Blogs
Existing anti-microbial drugs are becoming ineffective. If current trends continue, we could end up reliving conditions before the discovery of antibiotics, when infectious diseases...
Money
Shares of Teva Pharmaceutical Industries traded up 0.87% on Monday, hitting $62.52.